|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0760 AUD | +1.33% |
|
-8.43% | -10.59% |
Evolution of the Average Target: Neurizon Therapeutics Limited
Evolution of the Target Price: Neurizon Therapeutics Limited
Changes in Analyst Recommendations: Neurizon Therapeutics Limited
7c4f8cc5d.KEcn_CYjqweZYyGKtTUkG5OWj6E8aL0Ach9UB-ddbbU.SiRhk3Vs5UHJEBHC8HxXYr7i2ex5EP9vJWoXSYE5Id1tLFSXSEvyM-5RdA~91108ba88f61d2767b9091de02354cac
| 06/25/06 | FDA lifts clinical hold on Nuz-001 | RE |
| 06/25/06 | Neurizon Therapeutics says US FDA lifts clinical hold on NUZ-001 | RE |
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +273.33% | |||
| +23.84% | |||||
| +13.44% | |||||
| +24.43% | |||||
| +13.34% | |||||
| +22.14% | |||||
| +6.46% | |||||
| +15.53% | |||||
| +4.01% | |||||
| +7.29% | |||||
| Average | +40.38% | |||||
| Weighted average by Cap. | +16.76% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0750AUD
Average target price
0.2800AUD
Spread / Average Target
+273.33%
High Price Target
0.2800AUD
Spread / Highest target
+273.33%
Low Price Target
0.2800AUD
Spread / Lowest Target
+273.33%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0750AUD
Average target price
0.2800AUD
Spread / Average Target
+273.33%
Annual profits - Rate of surprise
- Stock Market
- Equities
- NUZ Stock
- Consensus Neurizon Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition